POM
PomDoctor Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CN
$1.61
+8.78%Nov 4, 2026, 13:00 UTC
Pomdoctor outlined its strategic evolution toward a four-tier revenue structure spanning B2C healthcare services, AI-enabled chronic disease management, B2B enterprise and hospital services, and pharmaceutical RWS/RWD services.
Source:Sep 30, 2026, 12:00 UTC
Pomdoctor Limited provided an update on the continued development and commercialization of its AI-enabled chronic disease management ecosystem, including optimization of its proprietary AI chronic disease management system, expanded real-world data applications, and integrated in-hospital and out-of-hospital chronic disease management pilots.
Source: